arrow
L

Laurent Villeneuve

hospices civils de lyon
H指数:45
被引数:7,178

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Structured operative reporting for cytoreductive surgery: the CRS-Report platform

细胞减灭术的结构化操作报告:CRS-Report平台

EJSO
IF2.9
2026-10-130
PRE
Prophylactic ureteral stenting during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Impact on symptomatic ureteral events requiring renal drainage

在细胞减灭术和温热腹腔化疗期间进行预防性输尿管支架置入:对需要肾脏引流的有症状输尿管事件的影响

EJSO
IF2.9
2026-10-120
OA
Principles of cytoreductive surgery for primary and metastatic peritoneal malignancies—the PSOGI–ESGO–ISSPP Lyon consensus

原发性及转移性腹膜恶性肿瘤细胞减灭术的原则——PSOGI–ESGO–ISSPP里昂共识

2026-03-300
PRE
Feasibility of ERAS guidelines for cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): An international multicenter study

ERAS指南在细胞减灭术联合或未联合温热腹腔灌注化疗(CRS-HIPEC)中的可行性:一项国际多中心研究

2026-01-310
OAAI
Proposed strategy after complete LAMN (low-grade appendiceal mucinous neoplasm) resection by different RENAPE units: need for a new consensus?

不同RENAPE单位在完全切除低级别阑尾黏液性肿瘤(LAMN)后的建议策略:是否需要新的共识?

2025-12-010
OAAI
Multiparametric assessment of tumor pathological regression grade of peritoneal metastases from non-mucinous colorectal cancer during neoadjuvant chemotherapy using dual-energy CT

使用双能量CT对非黏液性结直肠癌腹膜转移灶在化疗新辅助治疗期间进行多参数评估肿瘤病理退缩分级

2025-10-310
PRE
ASO Author Reflections: Preoperative Peritoneal MRI Used as the Peritoneal Surgeon’s Headlamp Helping to Achieve a Complete Cytoreductive Surgery in Patients with Abdominal Surgical History

ASO作者反思:作为腹腔外科医生“探照灯”的术前腹膜MRI,有助于在具有腹部手术史的患者中实现完全细胞减灭术。

2025-10-060
PRE
Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients

评估弥漫性恶性腹膜间皮瘤患者行完全细胞减灭术联合温热腹腔化疗(HIPEC)后的年度复发风险

2025-09-260
PRE
ASO Visual Abstract: Preoperative Peritoneal MRI: Usefulness to Highlight Potential Hidden Lesions for Complete Cytoreductive Surgery in Colorectal Cancer Patients with Surgical History

ASO视觉摘要:术前腹膜MRI:在具有手术史的大肠癌患者中,完全细胞减灭术用于突出潜在隐匿病灶的实用性

2025-09-090
PRE
Preoperative Peritoneal MRI: Usefulness to Highlight Potential Hidden Lesions for Complete Cytoreductive Surgery in Patients with Colorectal Cancer with Surgical History

术前腹膜MRI:用于结直肠癌有手术史患者的完全细胞减灭术,以突出潜在隐匿病灶的实用性

2025-08-060
OAAI
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial

奥拉帕利联合间质环磷酰胺和二甲双胍治疗复发性晚期/转移性子宫内膜癌的女性:ENDOLA I/II期试验

2025-02-200
OA
Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus

PSOGI-ESGO-ISSPP合作者。腹膜切除术治疗腹膜表面恶性肿瘤:PSOGI-ESGO-ISSPP里昂共识

2025-01-010
PRE
Peritonectomy to enhance adequate cytoreductive surgery in peritoneal surface malignancy: review of nomenclature and boundaries

腹膜切除术以增强腹膜表面恶性肿瘤的充分细胞减灭术:命名法和边界的综述

2025-01-010
PRE
ASO Visual Abstract: Management of the Uninvolved Uterus and Adnexa During Routine Pelvic Peritonectomy in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Varies by Histology and Menopausal Status-An International Survey of Peritoneal Surface Malignancy Surgeons
2024-12-170
PRE